Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annette Ekblond

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Stem Cell Research & Therapy|February 7, 2026
In vitro assays for investigating the immunomodulatory properties of human mesenchymal stromal cellsLaura Lykke Lethager, Stine Bangsgaard, Ellen Mønsted Johansen, et al.
European Heart Journal|May 1, 2015
Bone marrow-derived mesenchymal stromal cell treatment in patients with severe ischaemic heart failure: a randomized placebo-controlled trial (MSC-HF trial)Anders Bruun Mathiasen, Abbas Ali Qayyum, Erik Jørgensen, et al.
The Ocular Surface|November 30, 2020
Safety and feasibility of mesenchymal stem cell therapy in patients with aqueous deficient dry eye diseaseMichael Møller-Hansen, Ann-Cathrine Larsen, Peter Bjerre Toft, et al.
Future Cardiology|March 25, 2026
Adipose tissue-derived mesenchymal stromal cell therapy in nonischemic heart failure with reduced ejection fraction - ARIISE study designNadia Chaaban, Jens Kastrup, Kasper Rossing, et al.
Diagnostics (Basel, Switzerland)|January 21, 2023
[<sup>68</sup>Ga]Ga-NODAGA-E[(cRGDyK)]<sub>2</sub> and [<sup>64</sup>Cu]Cu-DOTATATE PET Predict Improvement in Ischemic CardiomyopathyBjarke Follin, Cecilie Hoeeg, Ingrid Hunter, et al.
ESC Heart Failure|July 23, 2024
Mesenchymal stromal cells to treat patients with non-ischaemic heart failure: Results from SCIENCE II pilot studyAbbas Ali Qayyum, Sabina Frljak, Morten Juhl, et al.
Stem Cell Research & Therapy|June 11, 2022
Adipose-derived stromal cells increase the formation of collagens through paracrine and juxtacrine mechanisms in a fibroblast co-culture model utilizing macromolecular crowdingRebekka Harary Søndergaard, Lisbeth Drozd Højgaard, Alexander Lynge Reese-Petersen, et al.
European Journal of Heart Failure|February 22, 2019
Rationale and design of the European multicentre study on Stem Cell therapy in IschEmic Non-treatable Cardiac diseasE (SCIENCE)Christina Paitazoglou, Martin W Bergmann, Bojan Vrtovec, et al.
International Journal of Molecular Sciences|November 13, 2021
The Initial Cardiac Tissue Response to Cryopreserved Allogeneic Adipose Tissue-Derived Mesenchymal Stromal Cells in Rats with Chronic Ischemic CardiomyopathyBjarke Follin, Cecilie Hoeeg, Lisbeth D Højgaard, et al.
The Ocular Surface|December 4, 2023
Allogeneic mesenchymal stem cell therapy for dry eye disease in patients with Sjögren's syndrome: A randomized clinical trialMichael Møller-Hansen, Ann-Cathrine Larsen, Anne K Wiencke, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Stem Cell Research & Therapy|February 7, 2026
In vitro assays for investigating the immunomodulatory properties of human mesenchymal stromal cellsLaura Lykke Lethager, Stine Bangsgaard, Ellen Mønsted Johansen, et al.
European Heart Journal|May 1, 2015
Bone marrow-derived mesenchymal stromal cell treatment in patients with severe ischaemic heart failure: a randomized placebo-controlled trial (MSC-HF trial)Anders Bruun Mathiasen, Abbas Ali Qayyum, Erik Jørgensen, et al.
The Ocular Surface|November 30, 2020
Safety and feasibility of mesenchymal stem cell therapy in patients with aqueous deficient dry eye diseaseMichael Møller-Hansen, Ann-Cathrine Larsen, Peter Bjerre Toft, et al.
Future Cardiology|March 25, 2026
Adipose tissue-derived mesenchymal stromal cell therapy in nonischemic heart failure with reduced ejection fraction - ARIISE study designNadia Chaaban, Jens Kastrup, Kasper Rossing, et al.
Diagnostics (Basel, Switzerland)|January 21, 2023
[<sup>68</sup>Ga]Ga-NODAGA-E[(cRGDyK)]<sub>2</sub> and [<sup>64</sup>Cu]Cu-DOTATATE PET Predict Improvement in Ischemic CardiomyopathyBjarke Follin, Cecilie Hoeeg, Ingrid Hunter, et al.
ESC Heart Failure|July 23, 2024
Mesenchymal stromal cells to treat patients with non-ischaemic heart failure: Results from SCIENCE II pilot studyAbbas Ali Qayyum, Sabina Frljak, Morten Juhl, et al.
Stem Cell Research & Therapy|June 11, 2022
Adipose-derived stromal cells increase the formation of collagens through paracrine and juxtacrine mechanisms in a fibroblast co-culture model utilizing macromolecular crowdingRebekka Harary Søndergaard, Lisbeth Drozd Højgaard, Alexander Lynge Reese-Petersen, et al.
European Journal of Heart Failure|February 22, 2019
Rationale and design of the European multicentre study on Stem Cell therapy in IschEmic Non-treatable Cardiac diseasE (SCIENCE)Christina Paitazoglou, Martin W Bergmann, Bojan Vrtovec, et al.
International Journal of Molecular Sciences|November 13, 2021
The Initial Cardiac Tissue Response to Cryopreserved Allogeneic Adipose Tissue-Derived Mesenchymal Stromal Cells in Rats with Chronic Ischemic CardiomyopathyBjarke Follin, Cecilie Hoeeg, Lisbeth D Højgaard, et al.
The Ocular Surface|December 4, 2023
Allogeneic mesenchymal stem cell therapy for dry eye disease in patients with Sjögren's syndrome: A randomized clinical trialMichael Møller-Hansen, Ann-Cathrine Larsen, Anne K Wiencke, et al.
Pageof 6